Policy | May 29, 2023
We need to focus on quality and affordable manufacturing: Mandaviya
Dr. Mandaviya urged the stakeholders to capitalize on the current opportunities
Dr. Mandaviya urged the stakeholders to capitalize on the current opportunities
Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
The product is expected to be launched in June 2023
The company has reported total income of Rs. 11303.95 crores during the period ended March 31, 2023
Indian government seeks to promote collaboration with stakeholders and harness potential for achieving growth and development of sector
Product deliveries scheduled in Q3 of 2023
Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
Lonza launches the TheraPEAK T-VIVO Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing
This is the second US FDA GMP inspection of this facility within one year
Subscribe To Our Newsletter & Stay Updated
